phorbol 12,13-dibutyrate has been researched along with daunorubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeRosa, WT; Hait, WN | 1 |
Fine, RL; Harrison, SD; Sachs, CW; Safa, AR | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and daunorubicin
Article | Year |
---|---|
The role of the phorbol ester receptor/protein kinase C in the sensitivity of leukemic cells to anthracyclines.
Topics: Antibiotics, Antineoplastic; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Phorbol 12,13-Dibutyrate; Protein Kinase C; Receptors, Drug; Tumor Cells, Cultured; Up-Regulation | 1991 |
Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Breast Neoplasms; Cell Line; Cell Membrane; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Phorbol 12,13-Dibutyrate; Protein Kinase C; Proteins; Rats; Recombinant Proteins; Sphingosine; Substrate Specificity; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |